leisure time -WSS

leisure time

author：focus 2025-10-02 22:39:45 - browse：45

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Medicare drug price lawsuits could be good politics for Biden

focus

WSS

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Medicare drug price lawsuits could be good politics for Biden

Kenai launches with $82 million for Parkinson’s stem cell therapy

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

FDA sets aggressive timeline for overhauling inspection procedures

CVS is on a mission to consolidate health care. Will it work?

Wikipedia

leisure time

knowledge

Bright Health sells Medicare Advantage business to Molina

HPV vaccine, cervical cancer study delivers historic results

Activists slam private health insurers over coverage restrictions

Pumping milk in bathrooms at health conferences is common

Medical records are filled with copy

AstraZeneca loses challenge to Medicare drug price negotiation

The high cost of giving birth even with insurance

How to address the problem of discarded donor organs

Medical records are filled with copy

In search for therapies for solid tumors, companies turn to claudin

hotspot

Medicare drug price lawsuits could be good politics for Biden

Immunocompromised patients offer clues on chronic Covid

The inclusion problem at the heart of rehabilitation research

TikTok, Instagram influencers need more rules for drug ads

How to fix the rural physician shortage in the U.S.

Why getting cancer drugs just got harder for rural patients

focus

leisure time

leisure time

focus